-+ 0.00%
-+ 0.00%
-+ 0.00%

BPL-003 PHASE 3 PROGRAM INITIATION ON TRACK FOR Q2 2026 FOLLOWING SUCCESSFUL FDA END-OF-PHASE 2 MEETING; ATAIBECKLEY HIGHLIGHTS KEY PIPELINE MILESTONES AT 2026 INVESTOR DAY

Reuters·03/10/2026 10:00:00

Please log in to view news